Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Apply
Pembrolizumab & Androgen-receptor Pathway Inhibitor
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step